Kurzfassung

A multicenter, randomized, open-lable, efficacy assessor blinded, activ comoratot controlled phase IIIb study to compare the efficacy of guselkumab of fumaric acid esters for adult patients of moderate to severe plaque psoriasis who are candidates for and naiv for systemic treatment